Back to Search
Start Over
Low-Density Lipoprotein Receptor Signaling Mediates the Triglyceride-Lowering Action of Akkermansia muciniphila in Genetic-Induced Hyperlipidemia
- Source :
- Arteriosclerosis, thrombosis, and vascular biology. 36(7)
- Publication Year :
- 2015
-
Abstract
- Objective— Akkermansia muciniphila (A muciniphila ) is a mucin-degrading bacterium that resides in the mucus layer whose abundance inversely correlates with body weight and the development of diabetes mellitus in mice and humans. The objective of this study was to explore the regulatory effect of A muciniphila on host lipoprotein metabolism, insulin sensitivity, and hepatic metabolic inflammation. Approach and Results— By establishing a novel mouse model that colonized the A muciniphila in the gastrointestinal tract of the cAMP-responsive binding protein H (CREBH)–deficient mouse and in vivo chylomicron assay, we found that increased colonization of A muciniphila in the gastrointestinal tract of wild-type mice protected mice from an acute fat load–induced hyperlipidemia compared with vehicle-treated mice. A muciniphila administration also significantly ameliorated chronic hypertriglyceridemia, improved insulin sensitivity, and prevented overproduction of postprandial chylomicrons in CREBH-null mice. Mechanistic studies revealed that increased A muciniphila colonization induced expression of low-density lipoprotein receptors and apolipoprotein E in the hepatocytes of CREBH-null mice, which facilitated the uptake of intermediate-density lipoprotein via the mediation of apolipoprotein B100 and apolipoprotein E, leading to the increased clearance of triglyceride-rich lipoprotein remnants, chylomicron remnants, and intermediate-density lipoproteins, from the circulation. Treatment with A muciniphila further improved hepatic endoplasmic reticulum stress and metabolic inflammation in CREBH-null mice. Conclusions— Increased colonization of the disease-protective gut bacteria A muciniphila protected the host from acute and chronic hyperlipidemia by enhancing the low-density lipoprotein receptor expression and alleviating hepatic endoplasmic reticulum stress and the inflammatory response in CREBH-null mice.
- Subjects :
- 0301 basic medicine
medicine.medical_specialty
Time Factors
Down-Regulation
030204 cardiovascular system & hematology
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Insulin resistance
Apolipoproteins E
Verrucomicrobia
Internal medicine
Hyperlipidemia
Chylomicrons
medicine
Animals
Genetic Predisposition to Disease
Cyclic AMP Response Element-Binding Protein
Triglycerides
Hypertriglyceridemia
Mice, Knockout
biology
Triglyceride
medicine.disease
biology.organism_classification
Endoplasmic Reticulum Stress
Gastrointestinal Microbiome
Gastrointestinal Tract
Mice, Inbred C57BL
Disease Models, Animal
030104 developmental biology
Postprandial
Endocrinology
Phenotype
chemistry
Lipoproteins, IDL
Liver
Receptors, LDL
LDL receptor
Apolipoprotein B-100
Host-Pathogen Interactions
Insulin Resistance
Cardiology and Cardiovascular Medicine
Akkermansia muciniphila
Biomarkers
Chylomicron
Signal Transduction
Subjects
Details
- ISSN :
- 15244636
- Volume :
- 36
- Issue :
- 7
- Database :
- OpenAIRE
- Journal :
- Arteriosclerosis, thrombosis, and vascular biology
- Accession number :
- edsair.doi.dedup.....47e195e9eabcdf89c838b929f9154c10